免疫肿瘤学检测市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

免疫肿瘤学检测市场按产品(试剂、抗体、仪器、软件、耗材和附件)、技术、适应症和地理细分。

免疫肿瘤学检测市场快照

immuno oncology assays market analysis
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 12.3 %
immuno oncology assays market major players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

研究的免疫肿瘤学检测市场预计在预测期内将以近 12.3% 的复合年增长率增长。导致市场增长的主要因素是癌症发病率的增加。根据世界卫生组织的数据,预计 2018 年全球癌症负担将上升至 1810 万新病例和 960 万人死亡。全球五分之一的男性和六分之一的女性在其一生中患上癌症,八分之一的男性和每 11 名妇女中就有 1 名死于这种疾病。此外,越来越多地采用靶向治疗正在推动市场增长。免疫肿瘤学检测用于测量治疗性抗体、抗药抗体和可溶性蛋白质生物标志物的浓度。随着靶向治疗的普及增加,检测的市场增长也在增加。然而,

报告范围

根据报告的范围,免疫肿瘤学检测是一种下一代测序应用程序,可提供免疫和肿瘤细胞动力学的实时自动测量。借助该测定,可以分析驱动针对癌症的免疫反应的生物学过程。它有助于持续检查和分析从增殖和激活到迁移和免疫细胞杀伤的关键事件,而不会干扰现有的身体细胞。本报告按产品、技术、适应症和地理细分。

By Product
Reagents and Antibodies
Instruments
Software
Consumables and Accessories
By Technology
Immunoassay
PCR
NGS
Flow Cytometry
Other Technologies
By Indication
Lung Cancer
Colorectal Cancer
Melanoma
Other Cancers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

试剂和抗体部门正在主导免疫肿瘤学检测市场。

由于对产品的需求增加等因素,试剂和抗体部分在市场上占有最大份额。需求与全球几种癌症发病率的增加成正比。如前所述,根据世界卫生组织的报告,2018 年全球癌症负担已上升至 1810 万例新病例。癌症负担的增加是由许多因素造成的,包括人口增长和老龄化,以及与社会和经济发展相关的某些癌症原因的频率变化。就新病例数量而言,肺癌和女性乳腺癌是全球最高的类别,对于这些类型中的每一种,2018 年估计约有 210 万例诊断,占癌症总发病率负担的约 11.6%。

immuno oncology assays market share

北美在市场上占主导地位,预计在预测期内也会如此

在整个预测期内,预计北美将主导整个市场。市场增长是由于关键参与者的存在、该地区癌症的高发病率、成熟的医疗保健基础设施等因素造成的,这些因素是其在市场上占有很大份额的一些关键因素。此外,有益的政府举措和研究合作伙伴数量的增加是预计增加市场增长的一些驱动因素。由于支持性医疗保健政策、大量患者和发达的医疗保健市场,美国在该地区的份额最大。根据美国国立卫生研究院 (NIH) 的数据,2018 年,美国估计将发现 1,735,350 例新的癌症病例,将有 609,640 人死于该病。

immuno oncology assays market forecast

竞争格局

免疫肿瘤学检测市场竞争适度,由几个主要参与者组成。目前主导市场的一些公司是安捷伦科技公司、赛默飞世尔科技、Cisbio、Illumina, Inc.、珀金埃尔默公司、皇冠生物科学公司、InSphero.、默克公司、F. Hoffmann -La Roche Ltd.、HTG Molecular Diagnostics, Inc.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Incidence of Cancer Globally

      2. 4.2.2 Increasing Adoption of Targeted Therapy

    3. 4.3 Market Restraints

      1. 4.3.1 Unfavorable Regulatory and Reimbursement Scenario

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Reagents and Antibodies

      2. 5.1.2 Instruments

      3. 5.1.3 Software

      4. 5.1.4 Consumables and Accessories

    2. 5.2 By Technology

      1. 5.2.1 Immunoassay

      2. 5.2.2 PCR

      3. 5.2.3 NGS

      4. 5.2.4 Flow Cytometry

      5. 5.2.5 Other Technologies

    3. 5.3 By Indication

      1. 5.3.1 Lung Cancer

      2. 5.3.2 Colorectal Cancer

      3. 5.3.3 Melanoma

      4. 5.3.4 Other Cancers

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies, Inc

      2. 6.1.2 Thermo Fisher Scientific

      3. 6.1.3 Illumina, Inc.

      4. 6.1.4 PerkinElmer, Inc.

      5. 6.1.5 Crown Bioscience Inc.

      6. 6.1.6 InSphero.

      7. 6.1.7 Merck & Company, Inc.

      8. 6.1.8 F. Hoffmann-La Roche Ltd.

      9. 6.1.9 HTG Molecular Diagnostics, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Immuno Oncology Assays Market market is studied from 2018 - 2026.

The Immuno Oncology Assays Market is growing at a CAGR of 12.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Agilent Technologies, Inc, Thermo Fisher Scientific, Crown Bioscience Inc., Illumina, Inc., PerkinElmer, Inc. are the major companies operating in Immuno Oncology Assays Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!